Evaluating the Impact of Sleep on Psoriasis and Associated Comorbidities
Sleep impairment is a risk factor for cardiovascular disease and metabolic disorders. Research shows that psoriasis patients are more likely to report sleep disturbance compared to people without psoriasis. This proposal aims to objectively measure sleep disturbance in psoriasis patients, describe differences in sleep patterns between psoriasis patients and controls, and determine whether sleep is a modifier for the development of psoriasis-associated cardiometabolic comorbidities.
— Tina Bhutani, M.D., MAS
- University of California, San Francisco
- Medical Dermatology Career Development Award
Categories: Featured Researchers
Tags: 2021 Research Awards, Psoriasis
Related Articles
Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia
Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather…
Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus
Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant…
Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy
Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent…